drugset / Trial / NCT02477566

Comparative Study of Long-acting and Short Acting Triptorelin in PCOS Patients Who Underwent IVF/ICSI

NCT02477566

Unknown 200 enrolled Nanjing University
RandomizedParallel-groupDouble-blindTreatment

Summary

To test whether long-acting Triptorelin on pituitary down-regulation can improve the clinical pregnancy rate and reduces the incidence of ovarian hyperstimulation syndrome (OHSS) in infertile high-risk patients with polycystic ovaries (PCOs) who underwent in vitro fertilization (IVF) or Intracytoplasmic sperm injection

Timeline

Start
2014-12
Primary completion
2016-12
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Triptorelin Other / unclassified 0.05 mg
Subject Triptorelin Other / unclassified 1.875 mg